Skip to main content
Shaperon Inc. logo

Shaperon Inc. — Investor Relations & Filings

Ticker · 378800 ISIN · KR7378800007 KO Manufacturing
Open in API
Filings indexed 146 across all filing types
Latest filing 2023-03-30 Board/Management Inform…
Country KR South Korea
Listing KO 378800

About Shaperon Inc.

https://www.shaperon.com/

Shaperon Inc. is a clinical-stage biotechnology company that develops novel immune therapeutics for inflammatory diseases. The company's primary focus is on the development of innovative inflammasome inhibitors. Its core technology is based on a unique mechanism that modulates the GPCR19-P2X7 pathway to regulate the initiation and progression of inflammatory responses. This approach is applied to a pipeline of drug candidates targeting various inflammation-driven conditions.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment and resignation of an outside director (사외이사). This falls under the category of board and management changes, specifically the 'Board/Management Information' category.
2023-03-30 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Amendment Report). It details the granting of stock options to employees and executives, including the legal basis, exercise conditions, and fair value calculations. This type of disclosure regarding capital structure changes and equity-based compensation falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the Korea Exchange/Financial Supervisory Service that does not fit into the other specialized categories like DIRS (which is for individual director trades) or SHA (which is for general share issuance).
2023-03-30 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from a Korean company (Chaperon) titled 'Audit Report Submission' (감사보고서 제출). It provides the auditor's opinion (unqualified/appropriate), key financial data (assets, liabilities, revenue, profit/loss), and details regarding the audit process. While it contains financial data, it is a standalone regulatory disclosure of the audit results rather than a full Annual Report (10-K) or an interim report. Therefore, it falls under the Audit Report/Information category. FY 2022
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the company 'Shaperon' (주식회사 샤페론) for the fiscal year 2022. It contains detailed financial information, company history, management structure, and business operations. In the context of Korean corporate filings, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report, as it is the comprehensive annual disclosure document submitted to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). FY 2022
2023-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Shaperon Co., Ltd. It outlines the meeting date, location, agenda items (such as approval of financial statements, election of directors, and remuneration limits), and provides management reference materials (business overview, financial highlights, and governance information). This document is a standard proxy statement/notice package sent to shareholders to inform them of an upcoming Annual General Meeting (AGM) and to solicit their votes. Therefore, it is classified as Proxy Solicitation & Information Statement.
2023-03-15 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company (Shaperon) is holding its AGM on a date that coincides with other companies, citing audit schedules and fiscal closing timelines. Since this is a specific regulatory disclosure regarding meeting logistics rather than the meeting materials themselves, the proxy statement, or the results, it falls under the general regulatory filing category.
2023-03-15 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.